glypican 3
| GO Term | Evidence Code | PMID |
|---|---|---|
| branching involved in ureteric bud morphogenesis |
|
|
| kidney development |
|
|
| negative regulation of cell population proliferation |
|
|
| response to bacterium |
|
|
| animal organ morphogenesis |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
|
| plasma membrane |
|
|
| cell surface |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein binding |
|
|
| peptidyl-dipeptidase inhibitor activity |
|
|
| peptidyl-dipeptidase inhibitor activity |
|
|
| peptidyl-dipeptidase inhibitor activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060248 | Simpson-Golabi-Behmel syndrome type 1 |
| Species | Gene ID | Alliance of Genome Resources |
|---|---|---|
| 25236 | RGD:2725 | |
| 39013 | FB:FBgn0263930 | |
| 2719 | HGNC:4451 | |
| 387365 | ZFIN:ZDB-GENE-031212-1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026